V. Leguy‐Seguin

839 total citations
28 papers, 424 citations indexed

About

V. Leguy‐Seguin is a scholar working on Genetics, Physiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, V. Leguy‐Seguin has authored 28 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 11 papers in Physiology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in V. Leguy‐Seguin's work include Lysosomal Storage Disorders Research (6 papers), Vascular Anomalies and Treatments (6 papers) and Tracheal and airway disorders (4 papers). V. Leguy‐Seguin is often cited by papers focused on Lysosomal Storage Disorders Research (6 papers), Vascular Anomalies and Treatments (6 papers) and Tracheal and airway disorders (4 papers). V. Leguy‐Seguin collaborates with scholars based in France, Switzerland and Belgium. V. Leguy‐Seguin's co-authors include Bernard Bonnotte, Evelyne Collet, Sylvain Audia, P. Vabres, S. Berthier, Bruno Coudert, S. Dalac, M. Samson, Christian Lavigne and Maxime Samson and has published in prestigious journals such as PLoS ONE, Journal of Allergy and Clinical Immunology and Frontiers in Immunology.

In The Last Decade

V. Leguy‐Seguin

21 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Leguy‐Seguin France 11 134 122 96 95 88 28 424
Sandra M. J. Paulissen Netherlands 9 72 0.5× 149 1.2× 189 2.0× 88 0.9× 45 0.5× 13 576
P.V. Voulgari Greece 12 92 0.7× 46 0.4× 279 2.9× 51 0.5× 53 0.6× 29 539
Yasuyuki Kamata Japan 11 77 0.6× 45 0.4× 125 1.3× 63 0.7× 37 0.4× 30 455
R. Ortega Castro Spain 13 60 0.4× 65 0.5× 216 2.3× 103 1.1× 10 0.1× 37 463
M Binaghi France 12 55 0.4× 20 0.2× 106 1.1× 20 0.2× 73 0.8× 35 518
Krzysztof Kowal Poland 12 30 0.2× 174 1.4× 25 0.3× 124 1.3× 17 0.2× 27 385
Hongbin Li China 9 26 0.2× 77 0.6× 130 1.4× 105 1.1× 9 0.1× 23 278
Ayla Yalamanoglu United States 13 126 0.9× 127 1.0× 19 0.2× 32 0.3× 129 1.5× 20 442
Christian Massot France 10 99 0.7× 23 0.2× 166 1.7× 77 0.8× 291 3.3× 32 549

Countries citing papers authored by V. Leguy‐Seguin

Since Specialization
Citations

This map shows the geographic impact of V. Leguy‐Seguin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Leguy‐Seguin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Leguy‐Seguin more than expected).

Fields of papers citing papers by V. Leguy‐Seguin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Leguy‐Seguin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Leguy‐Seguin. The network helps show where V. Leguy‐Seguin may publish in the future.

Co-authorship network of co-authors of V. Leguy‐Seguin

This figure shows the co-authorship network connecting the top 25 collaborators of V. Leguy‐Seguin. A scholar is included among the top collaborators of V. Leguy‐Seguin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Leguy‐Seguin. V. Leguy‐Seguin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maillot, F., Alain Fouilhoux, L. Astudillo, et al.. (2025). Bone mineral density in French adults with early-treated phenylketonuria. Molecular Genetics and Metabolism. 144(3). 109044–109044.
2.
Dupuis‐Girod, Sophie, Évelyne Decullier, Sophie Rivière, et al.. (2025). BEST study: one-year descriptive follow-up of bevacizumab treatment in hereditary haemorrhagic telangiectasia post-BABH interventional study. Therapeutic Advances in Hematology. 16. 1574218588–1574218588.
3.
Charrière, Sybil, Claire Douillard, Alain Fouilhoux, et al.. (2024). Neuropsychological profile of French adults with early-treated phenylketonuria: a multicenter study. Journal of Neurology. 272(1). 53–53.
4.
Razanamahery, Jérôme, et al.. (2023). Impact of BRAFV600E mutation on aggressiveness and outcomes in adult clonal histiocytosis. Frontiers in Immunology. 14. 1260193–1260193.
5.
Mauhin, Wladimir, Abdellah Tebani, Damien Amelin, et al.. (2022). Sphingosine-1-Phosphate Levels Are Higher in Male Patients with Non-Classic Fabry Disease. Journal of Clinical Medicine. 11(5). 1233–1233. 3 indexed citations
6.
Serratrice, J., P. Chérìn, Olivier Lidove, et al.. (2019). Coagulation Parameters in Adult Patients With Type-1 Gaucher Disease. Journal of Hematology. 8(3). 121–124. 4 indexed citations
7.
Audia, Sylvain, M. Samson, Daniela Lakomy, et al.. (2018). Venous thromboembolic events during warm autoimmune hemolytic anemia. PLoS ONE. 13(11). e0207218–e0207218. 55 indexed citations
8.
Revuz, Sabine, Évelyne Decullier, Isabelle Ginon, et al.. (2017). Pulmonary hypertension subtypes associated with hereditary haemorrhagic telangiectasia: Haemodynamic profiles and survival probability. PLoS ONE. 12(10). e0184227–e0184227. 20 indexed citations
9.
Lorcerie, B., Sylvain Audia, Maxime Samson, et al.. (2017). Diagnosis of hyperferritinemia in routine clinical practice. La Presse Médicale. 46(12). e329–e338. 26 indexed citations
10.
Samson, M., A Guilhem, V. Leguy‐Seguin, et al.. (2017). Efficacy and safety of dapsone as second line therapy for adult immune thrombocytopenia: A retrospective study of 42 patients. PLoS ONE. 12(10). e0187296–e0187296. 16 indexed citations
11.
Bouiller, Kévin, Sylvain Audia, H. Devilliers, et al.. (2016). Etiologies and prognostic factors of leukocytoclastic vasculitis with skin involvement. Medicine. 95(28). e4238–e4238. 33 indexed citations
12.
Maillet, Thibault, V. Leguy‐Seguin, M. Samson, et al.. (2016). Pseudotumeur rénale : une forme trompeuse de maladie associée aux IgG4. La Revue de Médecine Interne. 37. A206–A207.
13.
Lorcerie, B., Sylvain Audia, Maxime Samson, et al.. (2015). Démarche diagnostique devant une hyperferritinémie. La Revue de Médecine Interne. 36(8). 522–529. 9 indexed citations
14.
Azzopardi, Nicolas, Sophie Dupuis‐Girod, David Ternant, et al.. (2015). Dose – response relationship of bevacizumab in hereditary hemorrhagic telangiectasia. mAbs. 7(3). 630–637. 16 indexed citations
15.
Kaminsky, P., Esther Noël, R. Jaussaud, et al.. (2013). Multidimensional analysis of clinical symptoms in patients with Fabry’s disease. International Journal of Clinical Practice. 67(2). 120–127. 13 indexed citations
16.
Samson, Maxime, Sylvain Audia, Agnès Jacquin, et al.. (2013). Incidence et caractéristiques des accidents vasculaires cérébraux associés à l’artérite à cellules géantes. La Revue de Médecine Interne. 34. A74–A75.
17.
Audia, Sylvain, Nicolas Falvo, V. Leguy‐Seguin, et al.. (2011). Scalp vein thrombosis mimicking giant cell arteritis relapse. Internal Medicine Journal. 41(6). 492–495. 3 indexed citations
18.
Kaminsky, P., Esther Noël, R. Jaussaud, et al.. (2011). Analyse multivariée d’une cohorte de 108 patients porteurs de la maladie de Fabry. Observatoire français médecine interne - Maladie de Fabry. La Revue de Médecine Interne. 32. S73–S73. 1 indexed citations
19.
Audia, Sylvain, Daniela Lakomy, Julien Guy, et al.. (2010). Traitement du purpura thrombopénique immunologique : étude rétrospective de 40 patients. La Revue de Médecine Interne. 31(5). 337–344. 5 indexed citations
20.
Leguy‐Seguin, V., et al.. (2007). Diagnostic and predictive value of skin testing in platinum salt hypersensitivity. Journal of Allergy and Clinical Immunology. 119(3). 726–730. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026